Files in this item
|(no description provided)|
|Title:||The cardiovascular effects of the pharmacological interruption of the brain renin-angiotensin system in Dahl salt-induced hypertension|
|Author(s):||Lark, Lisa Anne|
|Doctoral Committee Chair(s):||Weyhenmeyer, James A.|
|Department / Program:||Neuroscience|
|Degree Granting Institution:||University of Illinois at Urbana-Champaign|
|Abstract:||The brain renin-angiotensin system (RAS) is a known regulator of cardiovascular function. The present studies investigated the cardiovascular effects of the pharmacological interruption of this system in hypertensive inbred Dahl salt-sensitive (DS/JR) rats.
Intracerebroventricular (i.c.v.) administration of the angiotensin converting enzyme inhibitor captopril (10 $\mu$g) to conscious, freely moving DS/JR rats produced a sustained depressor response but was without effect in normotensive control inbred Dahl salt-resistant rats.
Remaining studies focused on the effects of centrally administered peptide and nonpeptide angiotensin II (ANG II) antagonists in DS/JR rats. Both the peptide antagonist sarthran (20 $\mu$g) and the nonpeptide antagonist losartan (10 $\mu$g), which is specific to the AT$\sb1$ receptor subtype, blocked pressor and dipsogenic responses to i.c.v. ANG II. The AT$\sb2$ receptor antagonist PD 123319 (10 $\mu$g) did not block the responses. Sarthran alone produced a significant and short-lived bradycardia with an accompanying slight depressor response. Losartan and PD 123319 were without effect on blood pressure and heart rate.
The sarthran-induced bradycardia was further evaluated by examining its magnitude after preblockade of one or both of the ANG II receptor subtypes. Both losartan and PD 123319 (10 $\mu$g) inhibited the bradycardic response to 20 $\mu$g of sarthran by about 45%. Preblockade of both sites resulted in a slightly greater inhibition suggesting that sarthran's effects are mediated interdependently by the AT$\sb1$ and AT$\sb2$ sites.
In summary, the present studies demonstrated that the brain RAS is involved in cardiovascular regulation in the DS/JR rat and, as such, may be a potential target for the treatment of salt-induced hypertension. Furthermore, evidence was presented which suggests that both ANG II receptor subtypes are involved in this function.
|Rights Information:||Copyright 1994 Lark, Lisa Anne|
|Date Available in IDEALS:||2011-05-07|
|Identifier in Online Catalog:||AAI9416390|